There were 1,758 press releases posted in the last 24 hours and 399,602 in the last 365 days.

2018 Report: New Pharma Models for a New Healthcare Era with Case Study Analysis

Dublin, June 27, 2019 (GLOBE NEWSWIRE) -- The "New Pharma Models for a New Healthcare Era" report has been added to ResearchAndMarkets.com's offering.

The entry of technology players into healthcare, alongside empowered consumers and payers' singular focus on cost-effective outcomes, is forcing change across all of pharma's traditional functions. Modern pharma needs to build new kinds of relationships, with each other, with tech players, and with healthcare providers and payers.

Key Topics Covered

OVERVIEW

THE REIMAGINING OF HEALTHCARE
Out with the old, in with the new: how pharma is changing along the value chain
Bibliography

CASE STUDIES
Fresenius: integrating care using data
Novo Nordisk: from drugmaker to data collector
Roche: data curator
Sanofi partners for a place in China's health delivery revolution
LEO Pharma: building trust by putting the patient first
Amgen: from transactional to collaborative
Bibliography

TECHNOLOGY FIRMS ARE REAL COMPETITORS
Big pharma is up against big tech
Tech firms are hiring healthcare talent
Tech is cozying up to payers and providers
Pharma has been slow to see the tech threat
Bibliography

DIGITAL PRODUCTS CAN ENHANCE DRUG PORTFOLIOS
Digital therapeutics may enhance drug portfolios with patient data
Pharma is investing in digital therapeutics
Digital health firms are working with providers
Data-collecting pills to boost outcomes
Proteus Digital Health: turning pharma's model on its head?
Bibliography

CHALLENGES TO EMBRACING NEW TECHS AND NEW PARTNERS
Do better relationships make money?
The challenges to embracing digital
Bibliography

LESSONS FROM OTHER SECTORS
Focus on what the customer wants
Consultants also take a cross-sectoral view
Bibliography

21ST CENTURY PHARMA: COLLABORATIVE SOLUTION PROVIDERS
Bibliography

APPENDIX
Scope
Methodology

LIST OF FIGURES
Figure 1: Old vs new pharma business models
Figure 2: Challenges to embracing the digital business model in pharma
Figure 3: All change: pharma's new look in a patient-centric, digitalized healthcare world

LIST OF TABLES
Table 1: Changes in key pharma activities in the new healthcare landscape
Table 2: Takeaways of case studies illustrating changing business models

For more information about this report visit https://www.researchandmarkets.com/r/c8pj0d

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

CONTACT: ResearchAndMarkets.com
         Laura Wood, Senior Press Manager
         press@researchandmarkets.com
         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900
Related Topics: Healthcare Services, Pharmaceuticals

22157.jpg